nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—ABCB1—Mitomycin—stomach cancer	0.219	0.39	CbGbCtD
Levomilnacipran—CYP2C8—Fluorouracil—stomach cancer	0.0798	0.142	CbGbCtD
Levomilnacipran—ABCB1—Irinotecan—stomach cancer	0.0563	0.0999	CbGbCtD
Levomilnacipran—ABCB1—Docetaxel—stomach cancer	0.0413	0.0732	CbGbCtD
Levomilnacipran—CYP3A4—Irinotecan—stomach cancer	0.0337	0.0599	CbGbCtD
Levomilnacipran—ABCB1—Doxorubicin—stomach cancer	0.0307	0.0546	CbGbCtD
Levomilnacipran—ABCB1—Methotrexate—stomach cancer	0.0298	0.0529	CbGbCtD
Levomilnacipran—CYP2D6—Doxorubicin—stomach cancer	0.029	0.0514	CbGbCtD
Levomilnacipran—CYP3A4—Docetaxel—stomach cancer	0.0247	0.0439	CbGbCtD
Levomilnacipran—CYP3A4—Doxorubicin—stomach cancer	0.0184	0.0327	CbGbCtD
Levomilnacipran—CYP2J2—blood vessel—stomach cancer	0.00404	0.194	CbGeAlD
Levomilnacipran—CYP2J2—endocrine gland—stomach cancer	0.00123	0.0592	CbGeAlD
Levomilnacipran—SLC6A4—hematopoietic system—stomach cancer	0.00116	0.0556	CbGeAlD
Levomilnacipran—CYP2J2—liver—stomach cancer	0.00111	0.0534	CbGeAlD
Levomilnacipran—CYP2C19—hematopoietic system—stomach cancer	0.00096	0.0461	CbGeAlD
Levomilnacipran—CYP2C8—hematopoietic system—stomach cancer	0.000838	0.0402	CbGeAlD
Levomilnacipran—SLC6A4—digestive system—stomach cancer	0.000806	0.0387	CbGeAlD
Levomilnacipran—ABCB1—blood vessel—stomach cancer	0.000755	0.0362	CbGeAlD
Levomilnacipran—CYP2C19—digestive system—stomach cancer	0.000668	0.032	CbGeAlD
Levomilnacipran—SLC6A4—endocrine gland—stomach cancer	0.000666	0.0319	CbGeAlD
Levomilnacipran—SLC6A2—endocrine gland—stomach cancer	0.000586	0.0281	CbGeAlD
Levomilnacipran—CYP3A4—hematopoietic system—stomach cancer	0.000568	0.0272	CbGeAlD
Levomilnacipran—CYP2D6—hematopoietic system—stomach cancer	0.000559	0.0268	CbGeAlD
Levomilnacipran—CYP2C19—endocrine gland—stomach cancer	0.000552	0.0265	CbGeAlD
Levomilnacipran—CYP2C19—liver—stomach cancer	0.000497	0.0239	CbGeAlD
Levomilnacipran—CYP2C8—endocrine gland—stomach cancer	0.000482	0.0231	CbGeAlD
Levomilnacipran—Urethral disorder—Methotrexate—stomach cancer	0.000469	0.00142	CcSEcCtD
Levomilnacipran—Infection—Docetaxel—stomach cancer	0.000469	0.00142	CcSEcCtD
Levomilnacipran—Weight decreased—Doxorubicin—stomach cancer	0.000468	0.00142	CcSEcCtD
Levomilnacipran—Diarrhoea—Irinotecan—stomach cancer	0.000467	0.00142	CcSEcCtD
Levomilnacipran—Dry mouth—Capecitabine—stomach cancer	0.000466	0.00141	CcSEcCtD
Levomilnacipran—Shock—Docetaxel—stomach cancer	0.000464	0.00141	CcSEcCtD
Levomilnacipran—Nervous system disorder—Docetaxel—stomach cancer	0.000463	0.0014	CcSEcCtD
Levomilnacipran—Pruritus—Fluorouracil—stomach cancer	0.000462	0.0014	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Docetaxel—stomach cancer	0.000462	0.0014	CcSEcCtD
Levomilnacipran—Tachycardia—Docetaxel—stomach cancer	0.00046	0.0014	CcSEcCtD
Levomilnacipran—Skin disorder—Docetaxel—stomach cancer	0.000458	0.00139	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000458	0.00139	CcSEcCtD
Levomilnacipran—Infection—Capecitabine—stomach cancer	0.000454	0.00138	CcSEcCtD
Levomilnacipran—Erythema multiforme—Methotrexate—stomach cancer	0.000452	0.00137	CcSEcCtD
Levomilnacipran—Dizziness—Irinotecan—stomach cancer	0.000451	0.00137	CcSEcCtD
Levomilnacipran—Anorexia—Docetaxel—stomach cancer	0.00045	0.00136	CcSEcCtD
Levomilnacipran—Shock—Capecitabine—stomach cancer	0.000449	0.00136	CcSEcCtD
Levomilnacipran—Urinary tract infection—Doxorubicin—stomach cancer	0.000449	0.00136	CcSEcCtD
Levomilnacipran—Nervous system disorder—Capecitabine—stomach cancer	0.000448	0.00136	CcSEcCtD
Levomilnacipran—Hepatitis—Epirubicin—stomach cancer	0.000448	0.00136	CcSEcCtD
Levomilnacipran—Eye disorder—Methotrexate—stomach cancer	0.000447	0.00136	CcSEcCtD
Levomilnacipran—Diarrhoea—Fluorouracil—stomach cancer	0.000447	0.00136	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Capecitabine—stomach cancer	0.000447	0.00136	CcSEcCtD
Levomilnacipran—Tachycardia—Capecitabine—stomach cancer	0.000446	0.00135	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Epirubicin—stomach cancer	0.000446	0.00135	CcSEcCtD
Levomilnacipran—Cardiac disorder—Methotrexate—stomach cancer	0.000444	0.00135	CcSEcCtD
Levomilnacipran—Skin disorder—Capecitabine—stomach cancer	0.000444	0.00135	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Epirubicin—stomach cancer	0.000442	0.00134	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Capecitabine—stomach cancer	0.000442	0.00134	CcSEcCtD
Levomilnacipran—Oedema peripheral—Epirubicin—stomach cancer	0.000441	0.00134	CcSEcCtD
Levomilnacipran—Hypotension—Docetaxel—stomach cancer	0.000441	0.00134	CcSEcCtD
Levomilnacipran—Haematuria—Doxorubicin—stomach cancer	0.00044	0.00134	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Epirubicin—stomach cancer	0.00044	0.00134	CcSEcCtD
Levomilnacipran—Urethral disorder—Epirubicin—stomach cancer	0.000439	0.00133	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000437	0.00133	CcSEcCtD
Levomilnacipran—Anorexia—Capecitabine—stomach cancer	0.000435	0.00132	CcSEcCtD
Levomilnacipran—CYP2C8—liver—stomach cancer	0.000434	0.0208	CbGeAlD
Levomilnacipran—Angiopathy—Methotrexate—stomach cancer	0.000434	0.00132	CcSEcCtD
Levomilnacipran—Vomiting—Irinotecan—stomach cancer	0.000434	0.00132	CcSEcCtD
Levomilnacipran—Dizziness—Fluorouracil—stomach cancer	0.000432	0.00131	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Methotrexate—stomach cancer	0.000431	0.00131	CcSEcCtD
Levomilnacipran—Rash—Irinotecan—stomach cancer	0.00043	0.00131	CcSEcCtD
Levomilnacipran—Dermatitis—Irinotecan—stomach cancer	0.00043	0.0013	CcSEcCtD
Levomilnacipran—Chills—Methotrexate—stomach cancer	0.000429	0.0013	CcSEcCtD
Levomilnacipran—Headache—Irinotecan—stomach cancer	0.000427	0.0013	CcSEcCtD
Levomilnacipran—Hypotension—Capecitabine—stomach cancer	0.000427	0.0013	CcSEcCtD
Levomilnacipran—Insomnia—Docetaxel—stomach cancer	0.000427	0.0013	CcSEcCtD
Levomilnacipran—Paraesthesia—Docetaxel—stomach cancer	0.000424	0.00129	CcSEcCtD
Levomilnacipran—Erythema multiforme—Epirubicin—stomach cancer	0.000423	0.00129	CcSEcCtD
Levomilnacipran—Dyspnoea—Docetaxel—stomach cancer	0.000421	0.00128	CcSEcCtD
Levomilnacipran—Somnolence—Docetaxel—stomach cancer	0.000419	0.00127	CcSEcCtD
Levomilnacipran—Mental disorder—Methotrexate—stomach cancer	0.000419	0.00127	CcSEcCtD
Levomilnacipran—Eye disorder—Epirubicin—stomach cancer	0.000419	0.00127	CcSEcCtD
Levomilnacipran—Malnutrition—Methotrexate—stomach cancer	0.000417	0.00126	CcSEcCtD
Levomilnacipran—Flushing—Epirubicin—stomach cancer	0.000416	0.00126	CcSEcCtD
Levomilnacipran—Cardiac disorder—Epirubicin—stomach cancer	0.000416	0.00126	CcSEcCtD
Levomilnacipran—Vomiting—Fluorouracil—stomach cancer	0.000416	0.00126	CcSEcCtD
Levomilnacipran—Dyspepsia—Docetaxel—stomach cancer	0.000415	0.00126	CcSEcCtD
Levomilnacipran—Hepatitis—Doxorubicin—stomach cancer	0.000414	0.00126	CcSEcCtD
Levomilnacipran—Insomnia—Capecitabine—stomach cancer	0.000413	0.00125	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Doxorubicin—stomach cancer	0.000412	0.00125	CcSEcCtD
Levomilnacipran—Rash—Fluorouracil—stomach cancer	0.000412	0.00125	CcSEcCtD
Levomilnacipran—Dermatitis—Fluorouracil—stomach cancer	0.000412	0.00125	CcSEcCtD
Levomilnacipran—Paraesthesia—Capecitabine—stomach cancer	0.00041	0.00124	CcSEcCtD
Levomilnacipran—Decreased appetite—Docetaxel—stomach cancer	0.00041	0.00124	CcSEcCtD
Levomilnacipran—Headache—Fluorouracil—stomach cancer	0.000409	0.00124	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Doxorubicin—stomach cancer	0.000409	0.00124	CcSEcCtD
Levomilnacipran—Oedema peripheral—Doxorubicin—stomach cancer	0.000408	0.00124	CcSEcCtD
Levomilnacipran—Dysgeusia—Methotrexate—stomach cancer	0.000408	0.00124	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000407	0.00124	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Doxorubicin—stomach cancer	0.000407	0.00124	CcSEcCtD
Levomilnacipran—Dyspnoea—Capecitabine—stomach cancer	0.000407	0.00124	CcSEcCtD
Levomilnacipran—Fatigue—Docetaxel—stomach cancer	0.000407	0.00123	CcSEcCtD
Levomilnacipran—Angiopathy—Epirubicin—stomach cancer	0.000406	0.00123	CcSEcCtD
Levomilnacipran—Urethral disorder—Doxorubicin—stomach cancer	0.000406	0.00123	CcSEcCtD
Levomilnacipran—Nausea—Irinotecan—stomach cancer	0.000405	0.00123	CcSEcCtD
Levomilnacipran—SLC6A2—lymph node—stomach cancer	0.000405	0.0194	CbGeAlD
Levomilnacipran—Mediastinal disorder—Epirubicin—stomach cancer	0.000404	0.00123	CcSEcCtD
Levomilnacipran—Constipation—Docetaxel—stomach cancer	0.000403	0.00122	CcSEcCtD
Levomilnacipran—Dyspepsia—Capecitabine—stomach cancer	0.000402	0.00122	CcSEcCtD
Levomilnacipran—Chills—Epirubicin—stomach cancer	0.000402	0.00122	CcSEcCtD
Levomilnacipran—ABCB1—hematopoietic system—stomach cancer	0.000402	0.0193	CbGeAlD
Levomilnacipran—Decreased appetite—Capecitabine—stomach cancer	0.000397	0.00121	CcSEcCtD
Levomilnacipran—CYP3A4—digestive system—stomach cancer	0.000395	0.0189	CbGeAlD
Levomilnacipran—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000394	0.0012	CcSEcCtD
Levomilnacipran—Fatigue—Capecitabine—stomach cancer	0.000394	0.0012	CcSEcCtD
Levomilnacipran—Vision blurred—Methotrexate—stomach cancer	0.000393	0.00119	CcSEcCtD
Levomilnacipran—Mental disorder—Epirubicin—stomach cancer	0.000392	0.00119	CcSEcCtD
Levomilnacipran—Erythema multiforme—Doxorubicin—stomach cancer	0.000392	0.00119	CcSEcCtD
Levomilnacipran—Constipation—Capecitabine—stomach cancer	0.000391	0.00119	CcSEcCtD
Levomilnacipran—Malnutrition—Epirubicin—stomach cancer	0.00039	0.00118	CcSEcCtD
Levomilnacipran—CYP2D6—digestive system—stomach cancer	0.000388	0.0186	CbGeAlD
Levomilnacipran—Nausea—Fluorouracil—stomach cancer	0.000388	0.00118	CcSEcCtD
Levomilnacipran—Eye disorder—Doxorubicin—stomach cancer	0.000387	0.00118	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Docetaxel—stomach cancer	0.000386	0.00117	CcSEcCtD
Levomilnacipran—Flushing—Doxorubicin—stomach cancer	0.000385	0.00117	CcSEcCtD
Levomilnacipran—Cardiac disorder—Doxorubicin—stomach cancer	0.000385	0.00117	CcSEcCtD
Levomilnacipran—Flatulence—Epirubicin—stomach cancer	0.000384	0.00117	CcSEcCtD
Levomilnacipran—Tension—Epirubicin—stomach cancer	0.000383	0.00116	CcSEcCtD
Levomilnacipran—Dysgeusia—Epirubicin—stomach cancer	0.000382	0.00116	CcSEcCtD
Levomilnacipran—Angiopathy—Doxorubicin—stomach cancer	0.000376	0.00114	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Capecitabine—stomach cancer	0.000373	0.00113	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Doxorubicin—stomach cancer	0.000373	0.00113	CcSEcCtD
Levomilnacipran—Abdominal pain—Docetaxel—stomach cancer	0.000373	0.00113	CcSEcCtD
Levomilnacipran—Body temperature increased—Docetaxel—stomach cancer	0.000373	0.00113	CcSEcCtD
Levomilnacipran—Leukopenia—Methotrexate—stomach cancer	0.000373	0.00113	CcSEcCtD
Levomilnacipran—Chills—Doxorubicin—stomach cancer	0.000372	0.00113	CcSEcCtD
Levomilnacipran—Vision blurred—Epirubicin—stomach cancer	0.000367	0.00112	CcSEcCtD
Levomilnacipran—ABCB1—epithelium—stomach cancer	0.000367	0.0176	CbGeAlD
Levomilnacipran—Mental disorder—Doxorubicin—stomach cancer	0.000363	0.0011	CcSEcCtD
Levomilnacipran—Urticaria—Capecitabine—stomach cancer	0.000363	0.0011	CcSEcCtD
Levomilnacipran—Abdominal pain—Capecitabine—stomach cancer	0.000361	0.0011	CcSEcCtD
Levomilnacipran—Body temperature increased—Capecitabine—stomach cancer	0.000361	0.0011	CcSEcCtD
Levomilnacipran—Convulsion—Methotrexate—stomach cancer	0.000361	0.0011	CcSEcCtD
Levomilnacipran—Malnutrition—Doxorubicin—stomach cancer	0.000361	0.00109	CcSEcCtD
Levomilnacipran—Agitation—Epirubicin—stomach cancer	0.000358	0.00109	CcSEcCtD
Levomilnacipran—Flatulence—Doxorubicin—stomach cancer	0.000355	0.00108	CcSEcCtD
Levomilnacipran—Chest pain—Methotrexate—stomach cancer	0.000355	0.00108	CcSEcCtD
Levomilnacipran—Tension—Doxorubicin—stomach cancer	0.000354	0.00107	CcSEcCtD
Levomilnacipran—Dysgeusia—Doxorubicin—stomach cancer	0.000353	0.00107	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000352	0.00107	CcSEcCtD
Levomilnacipran—Syncope—Epirubicin—stomach cancer	0.00035	0.00106	CcSEcCtD
Levomilnacipran—Leukopenia—Epirubicin—stomach cancer	0.000349	0.00106	CcSEcCtD
Levomilnacipran—Hypersensitivity—Docetaxel—stomach cancer	0.000348	0.00105	CcSEcCtD
Levomilnacipran—Palpitations—Epirubicin—stomach cancer	0.000345	0.00105	CcSEcCtD
Levomilnacipran—Loss of consciousness—Epirubicin—stomach cancer	0.000343	0.00104	CcSEcCtD
Levomilnacipran—Vision blurred—Doxorubicin—stomach cancer	0.00034	0.00103	CcSEcCtD
Levomilnacipran—Asthenia—Docetaxel—stomach cancer	0.000338	0.00103	CcSEcCtD
Levomilnacipran—Convulsion—Epirubicin—stomach cancer	0.000338	0.00103	CcSEcCtD
Levomilnacipran—Infection—Methotrexate—stomach cancer	0.000338	0.00103	CcSEcCtD
Levomilnacipran—Hypertension—Epirubicin—stomach cancer	0.000337	0.00102	CcSEcCtD
Levomilnacipran—Hypersensitivity—Capecitabine—stomach cancer	0.000336	0.00102	CcSEcCtD
Levomilnacipran—Pruritus—Docetaxel—stomach cancer	0.000334	0.00101	CcSEcCtD
Levomilnacipran—Nervous system disorder—Methotrexate—stomach cancer	0.000333	0.00101	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Methotrexate—stomach cancer	0.000333	0.00101	CcSEcCtD
Levomilnacipran—Chest pain—Epirubicin—stomach cancer	0.000332	0.00101	CcSEcCtD
Levomilnacipran—Agitation—Doxorubicin—stomach cancer	0.000331	0.00101	CcSEcCtD
Levomilnacipran—Anxiety—Epirubicin—stomach cancer	0.000331	0.001	CcSEcCtD
Levomilnacipran—Skin disorder—Methotrexate—stomach cancer	0.00033	0.001	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00033	0.001	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Methotrexate—stomach cancer	0.000329	0.000998	CcSEcCtD
Levomilnacipran—Asthenia—Capecitabine—stomach cancer	0.000328	0.000995	CcSEcCtD
Levomilnacipran—ABCB1—pancreas—stomach cancer	0.000327	0.0157	CbGeAlD
Levomilnacipran—CYP3A4—endocrine gland—stomach cancer	0.000326	0.0156	CbGeAlD
Levomilnacipran—Dry mouth—Epirubicin—stomach cancer	0.000325	0.000985	CcSEcCtD
Levomilnacipran—Anorexia—Methotrexate—stomach cancer	0.000324	0.000984	CcSEcCtD
Levomilnacipran—Syncope—Doxorubicin—stomach cancer	0.000323	0.000982	CcSEcCtD
Levomilnacipran—Pruritus—Capecitabine—stomach cancer	0.000323	0.000981	CcSEcCtD
Levomilnacipran—Leukopenia—Doxorubicin—stomach cancer	0.000323	0.00098	CcSEcCtD
Levomilnacipran—Diarrhoea—Docetaxel—stomach cancer	0.000323	0.00098	CcSEcCtD
Levomilnacipran—CYP2D6—endocrine gland—stomach cancer	0.000321	0.0154	CbGeAlD
Levomilnacipran—Palpitations—Doxorubicin—stomach cancer	0.000319	0.000968	CcSEcCtD
Levomilnacipran—Hypotension—Methotrexate—stomach cancer	0.000318	0.000964	CcSEcCtD
Levomilnacipran—Loss of consciousness—Doxorubicin—stomach cancer	0.000317	0.000962	CcSEcCtD
Levomilnacipran—Infection—Epirubicin—stomach cancer	0.000316	0.000959	CcSEcCtD
Levomilnacipran—Shock—Epirubicin—stomach cancer	0.000313	0.00095	CcSEcCtD
Levomilnacipran—Convulsion—Doxorubicin—stomach cancer	0.000313	0.000949	CcSEcCtD
Levomilnacipran—Diarrhoea—Capecitabine—stomach cancer	0.000312	0.000948	CcSEcCtD
Levomilnacipran—Nervous system disorder—Epirubicin—stomach cancer	0.000312	0.000947	CcSEcCtD
Levomilnacipran—Dizziness—Docetaxel—stomach cancer	0.000312	0.000947	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Epirubicin—stomach cancer	0.000312	0.000946	CcSEcCtD
Levomilnacipran—Hypertension—Doxorubicin—stomach cancer	0.000311	0.000945	CcSEcCtD
Levomilnacipran—Tachycardia—Epirubicin—stomach cancer	0.000311	0.000943	CcSEcCtD
Levomilnacipran—Skin disorder—Epirubicin—stomach cancer	0.000309	0.000938	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Epirubicin—stomach cancer	0.000308	0.000934	CcSEcCtD
Levomilnacipran—Insomnia—Methotrexate—stomach cancer	0.000308	0.000933	CcSEcCtD
Levomilnacipran—Chest pain—Doxorubicin—stomach cancer	0.000307	0.000932	CcSEcCtD
Levomilnacipran—Anxiety—Doxorubicin—stomach cancer	0.000306	0.000929	CcSEcCtD
Levomilnacipran—Paraesthesia—Methotrexate—stomach cancer	0.000305	0.000927	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000305	0.000926	CcSEcCtD
Levomilnacipran—Anorexia—Epirubicin—stomach cancer	0.000303	0.000921	CcSEcCtD
Levomilnacipran—Dyspnoea—Methotrexate—stomach cancer	0.000303	0.00092	CcSEcCtD
Levomilnacipran—Somnolence—Methotrexate—stomach cancer	0.000302	0.000917	CcSEcCtD
Levomilnacipran—Dizziness—Capecitabine—stomach cancer	0.000302	0.000917	CcSEcCtD
Levomilnacipran—Dry mouth—Doxorubicin—stomach cancer	0.0003	0.000912	CcSEcCtD
Levomilnacipran—Vomiting—Docetaxel—stomach cancer	0.0003	0.00091	CcSEcCtD
Levomilnacipran—Dyspepsia—Methotrexate—stomach cancer	0.000299	0.000908	CcSEcCtD
Levomilnacipran—Rash—Docetaxel—stomach cancer	0.000297	0.000903	CcSEcCtD
Levomilnacipran—Hypotension—Epirubicin—stomach cancer	0.000297	0.000902	CcSEcCtD
Levomilnacipran—Dermatitis—Docetaxel—stomach cancer	0.000297	0.000902	CcSEcCtD
Levomilnacipran—Decreased appetite—Methotrexate—stomach cancer	0.000296	0.000897	CcSEcCtD
Levomilnacipran—Headache—Docetaxel—stomach cancer	0.000296	0.000897	CcSEcCtD
Levomilnacipran—CYP3A4—liver—stomach cancer	0.000294	0.0141	CbGeAlD
Levomilnacipran—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000294	0.000891	CcSEcCtD
Levomilnacipran—Fatigue—Methotrexate—stomach cancer	0.000293	0.00089	CcSEcCtD
Levomilnacipran—Infection—Doxorubicin—stomach cancer	0.000292	0.000888	CcSEcCtD
Levomilnacipran—Vomiting—Capecitabine—stomach cancer	0.00029	0.000881	CcSEcCtD
Levomilnacipran—Shock—Doxorubicin—stomach cancer	0.00029	0.000879	CcSEcCtD
Levomilnacipran—CYP2D6—liver—stomach cancer	0.000289	0.0139	CbGeAlD
Levomilnacipran—Nervous system disorder—Doxorubicin—stomach cancer	0.000289	0.000876	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Doxorubicin—stomach cancer	0.000288	0.000875	CcSEcCtD
Levomilnacipran—Rash—Capecitabine—stomach cancer	0.000288	0.000874	CcSEcCtD
Levomilnacipran—Insomnia—Epirubicin—stomach cancer	0.000288	0.000873	CcSEcCtD
Levomilnacipran—Dermatitis—Capecitabine—stomach cancer	0.000288	0.000873	CcSEcCtD
Levomilnacipran—Tachycardia—Doxorubicin—stomach cancer	0.000287	0.000872	CcSEcCtD
Levomilnacipran—Headache—Capecitabine—stomach cancer	0.000286	0.000868	CcSEcCtD
Levomilnacipran—Skin disorder—Doxorubicin—stomach cancer	0.000286	0.000868	CcSEcCtD
Levomilnacipran—Paraesthesia—Epirubicin—stomach cancer	0.000286	0.000867	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Doxorubicin—stomach cancer	0.000285	0.000864	CcSEcCtD
Levomilnacipran—Dyspnoea—Epirubicin—stomach cancer	0.000284	0.000861	CcSEcCtD
Levomilnacipran—ABCB1—lymphoid tissue—stomach cancer	0.000283	0.0136	CbGeAlD
Levomilnacipran—Somnolence—Epirubicin—stomach cancer	0.000283	0.000859	CcSEcCtD
Levomilnacipran—Anorexia—Doxorubicin—stomach cancer	0.000281	0.000852	CcSEcCtD
Levomilnacipran—Nausea—Docetaxel—stomach cancer	0.00028	0.00085	CcSEcCtD
Levomilnacipran—Dyspepsia—Epirubicin—stomach cancer	0.00028	0.00085	CcSEcCtD
Levomilnacipran—ABCB1—digestive system—stomach cancer	0.000279	0.0134	CbGeAlD
Levomilnacipran—Gastrointestinal pain—Methotrexate—stomach cancer	0.000278	0.000844	CcSEcCtD
Levomilnacipran—Decreased appetite—Epirubicin—stomach cancer	0.000277	0.00084	CcSEcCtD
Levomilnacipran—Hypotension—Doxorubicin—stomach cancer	0.000275	0.000835	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000275	0.000834	CcSEcCtD
Levomilnacipran—Fatigue—Epirubicin—stomach cancer	0.000274	0.000833	CcSEcCtD
Levomilnacipran—Constipation—Epirubicin—stomach cancer	0.000272	0.000826	CcSEcCtD
Levomilnacipran—Nausea—Capecitabine—stomach cancer	0.000271	0.000823	CcSEcCtD
Levomilnacipran—Urticaria—Methotrexate—stomach cancer	0.00027	0.00082	CcSEcCtD
Levomilnacipran—Body temperature increased—Methotrexate—stomach cancer	0.000269	0.000816	CcSEcCtD
Levomilnacipran—Abdominal pain—Methotrexate—stomach cancer	0.000269	0.000816	CcSEcCtD
Levomilnacipran—Insomnia—Doxorubicin—stomach cancer	0.000266	0.000808	CcSEcCtD
Levomilnacipran—Paraesthesia—Doxorubicin—stomach cancer	0.000264	0.000802	CcSEcCtD
Levomilnacipran—Dyspnoea—Doxorubicin—stomach cancer	0.000262	0.000797	CcSEcCtD
Levomilnacipran—Somnolence—Doxorubicin—stomach cancer	0.000262	0.000794	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Epirubicin—stomach cancer	0.00026	0.00079	CcSEcCtD
Levomilnacipran—Dyspepsia—Doxorubicin—stomach cancer	0.000259	0.000787	CcSEcCtD
Levomilnacipran—ABCB1—bone marrow—stomach cancer	0.000258	0.0124	CbGeAlD
Levomilnacipran—Decreased appetite—Doxorubicin—stomach cancer	0.000256	0.000777	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000254	0.000771	CcSEcCtD
Levomilnacipran—Fatigue—Doxorubicin—stomach cancer	0.000254	0.00077	CcSEcCtD
Levomilnacipran—Urticaria—Epirubicin—stomach cancer	0.000253	0.000767	CcSEcCtD
Levomilnacipran—Constipation—Doxorubicin—stomach cancer	0.000252	0.000764	CcSEcCtD
Levomilnacipran—Abdominal pain—Epirubicin—stomach cancer	0.000252	0.000763	CcSEcCtD
Levomilnacipran—Body temperature increased—Epirubicin—stomach cancer	0.000252	0.000763	CcSEcCtD
Levomilnacipran—Hypersensitivity—Methotrexate—stomach cancer	0.00025	0.00076	CcSEcCtD
Levomilnacipran—Asthenia—Methotrexate—stomach cancer	0.000244	0.00074	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000241	0.000731	CcSEcCtD
Levomilnacipran—Pruritus—Methotrexate—stomach cancer	0.000241	0.00073	CcSEcCtD
Levomilnacipran—Hypersensitivity—Epirubicin—stomach cancer	0.000234	0.000712	CcSEcCtD
Levomilnacipran—Urticaria—Doxorubicin—stomach cancer	0.000234	0.00071	CcSEcCtD
Levomilnacipran—Body temperature increased—Doxorubicin—stomach cancer	0.000233	0.000706	CcSEcCtD
Levomilnacipran—Abdominal pain—Doxorubicin—stomach cancer	0.000233	0.000706	CcSEcCtD
Levomilnacipran—Diarrhoea—Methotrexate—stomach cancer	0.000233	0.000706	CcSEcCtD
Levomilnacipran—ABCB1—endocrine gland—stomach cancer	0.000231	0.0111	CbGeAlD
Levomilnacipran—Asthenia—Epirubicin—stomach cancer	0.000228	0.000693	CcSEcCtD
Levomilnacipran—Pruritus—Epirubicin—stomach cancer	0.000225	0.000683	CcSEcCtD
Levomilnacipran—Dizziness—Methotrexate—stomach cancer	0.000225	0.000682	CcSEcCtD
Levomilnacipran—Diarrhoea—Epirubicin—stomach cancer	0.000218	0.000661	CcSEcCtD
Levomilnacipran—Hypersensitivity—Doxorubicin—stomach cancer	0.000217	0.000658	CcSEcCtD
Levomilnacipran—Vomiting—Methotrexate—stomach cancer	0.000216	0.000656	CcSEcCtD
Levomilnacipran—Rash—Methotrexate—stomach cancer	0.000214	0.000651	CcSEcCtD
Levomilnacipran—Dermatitis—Methotrexate—stomach cancer	0.000214	0.00065	CcSEcCtD
Levomilnacipran—Headache—Methotrexate—stomach cancer	0.000213	0.000646	CcSEcCtD
Levomilnacipran—Asthenia—Doxorubicin—stomach cancer	0.000211	0.000641	CcSEcCtD
Levomilnacipran—Dizziness—Epirubicin—stomach cancer	0.00021	0.000639	CcSEcCtD
Levomilnacipran—Pruritus—Doxorubicin—stomach cancer	0.000208	0.000632	CcSEcCtD
Levomilnacipran—ABCB1—liver—stomach cancer	0.000208	0.00999	CbGeAlD
Levomilnacipran—Vomiting—Epirubicin—stomach cancer	0.000202	0.000614	CcSEcCtD
Levomilnacipran—Nausea—Methotrexate—stomach cancer	0.000202	0.000613	CcSEcCtD
Levomilnacipran—Diarrhoea—Doxorubicin—stomach cancer	0.000201	0.000611	CcSEcCtD
Levomilnacipran—Rash—Epirubicin—stomach cancer	0.000201	0.000609	CcSEcCtD
Levomilnacipran—Dermatitis—Epirubicin—stomach cancer	0.0002	0.000608	CcSEcCtD
Levomilnacipran—Headache—Epirubicin—stomach cancer	0.000199	0.000605	CcSEcCtD
Levomilnacipran—Dizziness—Doxorubicin—stomach cancer	0.000195	0.000591	CcSEcCtD
Levomilnacipran—Nausea—Epirubicin—stomach cancer	0.000189	0.000574	CcSEcCtD
Levomilnacipran—Vomiting—Doxorubicin—stomach cancer	0.000187	0.000568	CcSEcCtD
Levomilnacipran—Rash—Doxorubicin—stomach cancer	0.000186	0.000563	CcSEcCtD
Levomilnacipran—Dermatitis—Doxorubicin—stomach cancer	0.000185	0.000563	CcSEcCtD
Levomilnacipran—Headache—Doxorubicin—stomach cancer	0.000184	0.00056	CcSEcCtD
Levomilnacipran—Nausea—Doxorubicin—stomach cancer	0.000175	0.000531	CcSEcCtD
Levomilnacipran—ABCB1—lymph node—stomach cancer	0.00016	0.00766	CbGeAlD
Levomilnacipran—CYP2C19—Metabolism—PPAP2A—stomach cancer	4.7e-05	0.000544	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—FBP1—stomach cancer	4.7e-05	0.000543	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CA1—stomach cancer	4.7e-05	0.000543	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NDUFA2—stomach cancer	4.7e-05	0.000543	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CKB—stomach cancer	4.7e-05	0.000543	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.69e-05	0.000542	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.66e-05	0.000539	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.63e-05	0.000535	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPAP2A—stomach cancer	4.59e-05	0.000531	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PGLS—stomach cancer	4.53e-05	0.000524	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—BLVRB—stomach cancer	4.53e-05	0.000524	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.52e-05	0.000523	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLIN2—stomach cancer	4.41e-05	0.00051	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ACAD8—stomach cancer	4.39e-05	0.000507	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPAP2A—stomach cancer	4.32e-05	0.0005	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CA2—stomach cancer	4.29e-05	0.000496	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARG—stomach cancer	4.29e-05	0.000496	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CA1—stomach cancer	4.19e-05	0.000484	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CKB—stomach cancer	4.19e-05	0.000484	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—FBP1—stomach cancer	4.19e-05	0.000484	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NDUFA2—stomach cancer	4.19e-05	0.000484	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PGAM1—stomach cancer	4.18e-05	0.000484	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NT5E—stomach cancer	4.18e-05	0.000484	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CKB—stomach cancer	4.09e-05	0.000473	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CA1—stomach cancer	4.09e-05	0.000473	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—FBP1—stomach cancer	4.09e-05	0.000473	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NDUFA2—stomach cancer	4.09e-05	0.000473	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—stomach cancer	4.07e-05	0.00047	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4.04e-05	0.000467	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLCE1—stomach cancer	3.99e-05	0.000462	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDH7A1—stomach cancer	3.99e-05	0.000462	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	3.95e-05	0.000456	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLIN2—stomach cancer	3.94e-05	0.000456	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GMPR2—stomach cancer	3.91e-05	0.000452	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALB—stomach cancer	3.86e-05	0.000446	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—FBP1—stomach cancer	3.85e-05	0.000446	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NDUFA2—stomach cancer	3.85e-05	0.000446	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CA1—stomach cancer	3.85e-05	0.000446	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CKB—stomach cancer	3.85e-05	0.000446	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLIN2—stomach cancer	3.85e-05	0.000445	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CA2—stomach cancer	3.83e-05	0.000443	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—UMPS—stomach cancer	3.83e-05	0.000442	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CA2—stomach cancer	3.74e-05	0.000433	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.74e-05	0.000432	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NT5E—stomach cancer	3.74e-05	0.000432	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PGAM1—stomach cancer	3.74e-05	0.000432	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NOS3—stomach cancer	3.69e-05	0.000427	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NT5E—stomach cancer	3.65e-05	0.000421	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PGAM1—stomach cancer	3.65e-05	0.000421	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLIN2—stomach cancer	3.62e-05	0.000419	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—IDH3B—stomach cancer	3.58e-05	0.000414	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.58e-05	0.000414	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.57e-05	0.000412	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH7A1—stomach cancer	3.56e-05	0.000412	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLCE1—stomach cancer	3.56e-05	0.000412	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.56e-05	0.000411	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PDHA1—stomach cancer	3.56e-05	0.000411	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ECHS1—stomach cancer	3.56e-05	0.000411	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CA2—stomach cancer	3.53e-05	0.000408	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLCE1—stomach cancer	3.48e-05	0.000402	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH7A1—stomach cancer	3.48e-05	0.000402	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.45e-05	0.000399	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NT5E—stomach cancer	3.44e-05	0.000397	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PGAM1—stomach cancer	3.44e-05	0.000397	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—UMPS—stomach cancer	3.42e-05	0.000395	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—stomach cancer	3.37e-05	0.00039	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.37e-05	0.000389	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TYMP—stomach cancer	3.35e-05	0.000387	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—FADS1—stomach cancer	3.35e-05	0.000387	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—UMPS—stomach cancer	3.33e-05	0.000385	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.33e-05	0.000384	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.33e-05	0.000384	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLCE1—stomach cancer	3.28e-05	0.000379	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH7A1—stomach cancer	3.28e-05	0.000379	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PDHA1—stomach cancer	3.18e-05	0.000367	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ECHS1—stomach cancer	3.18e-05	0.000367	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—UMPS—stomach cancer	3.14e-05	0.000363	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SREBF2—stomach cancer	3.13e-05	0.000362	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.11e-05	0.000359	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ECHS1—stomach cancer	3.1e-05	0.000358	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PDHA1—stomach cancer	3.1e-05	0.000358	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—RORA—stomach cancer	3.1e-05	0.000358	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—FADS1—stomach cancer	2.99e-05	0.000345	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TYMP—stomach cancer	2.99e-05	0.000345	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.98e-05	0.000345	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PGLS—stomach cancer	2.96e-05	0.000343	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—BLVRB—stomach cancer	2.96e-05	0.000343	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.94e-05	0.00034	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ECHS1—stomach cancer	2.92e-05	0.000338	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PDHA1—stomach cancer	2.92e-05	0.000338	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TYMP—stomach cancer	2.91e-05	0.000337	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—FADS1—stomach cancer	2.91e-05	0.000337	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDOB—stomach cancer	2.9e-05	0.000335	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.86e-05	0.000331	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.83e-05	0.000327	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.8e-05	0.000323	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.8e-05	0.000323	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SREBF2—stomach cancer	2.8e-05	0.000323	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—RORA—stomach cancer	2.76e-05	0.000319	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—FADS1—stomach cancer	2.75e-05	0.000318	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TYMP—stomach cancer	2.75e-05	0.000318	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.74e-05	0.000316	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SREBF2—stomach cancer	2.73e-05	0.000316	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.73e-05	0.000315	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—RORA—stomach cancer	2.7e-05	0.000312	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALOX5—stomach cancer	2.7e-05	0.000312	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.66e-05	0.000308	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—DPYD—stomach cancer	2.65e-05	0.000307	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.64e-05	0.000306	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDOB—stomach cancer	2.59e-05	0.000299	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SREBF2—stomach cancer	2.57e-05	0.000297	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—RORA—stomach cancer	2.54e-05	0.000294	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDOB—stomach cancer	2.53e-05	0.000292	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.52e-05	0.000291	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FBP1—stomach cancer	2.52e-05	0.000291	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CKB—stomach cancer	2.52e-05	0.000291	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CA1—stomach cancer	2.52e-05	0.000291	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.44e-05	0.000282	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.44e-05	0.000282	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.43e-05	0.000281	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALOX5—stomach cancer	2.41e-05	0.000278	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.4e-05	0.000278	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDOB—stomach cancer	2.38e-05	0.000275	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLIN2—stomach cancer	2.37e-05	0.000274	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—DPYD—stomach cancer	2.37e-05	0.000274	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALOX5—stomach cancer	2.35e-05	0.000272	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.35e-05	0.000272	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTT1—stomach cancer	2.35e-05	0.000271	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2A6—stomach cancer	2.32e-05	0.000268	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—DPYD—stomach cancer	2.31e-05	0.000267	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CA2—stomach cancer	2.3e-05	0.000266	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.26e-05	0.000261	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKR1C3—stomach cancer	2.26e-05	0.000261	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PGAM1—stomach cancer	2.25e-05	0.00026	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NT5E—stomach cancer	2.25e-05	0.00026	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALOX5—stomach cancer	2.21e-05	0.000256	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ENO1—stomach cancer	2.2e-05	0.000254	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—DPYD—stomach cancer	2.18e-05	0.000252	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.16e-05	0.00025	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.15e-05	0.000248	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.14e-05	0.000248	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLCE1—stomach cancer	2.14e-05	0.000248	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTT1—stomach cancer	2.09e-05	0.000242	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CA—stomach cancer	2.08e-05	0.00024	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2A6—stomach cancer	2.07e-05	0.000239	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—UMPS—stomach cancer	2.05e-05	0.000238	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTT1—stomach cancer	2.04e-05	0.000236	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2A6—stomach cancer	2.02e-05	0.000234	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKR1C3—stomach cancer	2.01e-05	0.000233	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKR1C3—stomach cancer	1.97e-05	0.000227	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ENO1—stomach cancer	1.96e-05	0.000227	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CD44—stomach cancer	1.95e-05	0.000225	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.93e-05	0.000223	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTT1—stomach cancer	1.93e-05	0.000223	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ENO1—stomach cancer	1.92e-05	0.000221	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ECHS1—stomach cancer	1.91e-05	0.000221	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PDHA1—stomach cancer	1.91e-05	0.000221	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.9e-05	0.00022	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.89e-05	0.000219	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.85e-05	0.000214	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ENO1—stomach cancer	1.8e-05	0.000209	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FADS1—stomach cancer	1.8e-05	0.000208	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TYMP—stomach cancer	1.8e-05	0.000208	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.79e-05	0.000207	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CD44—stomach cancer	1.74e-05	0.000201	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CD44—stomach cancer	1.7e-05	0.000196	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.69e-05	0.000195	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SREBF2—stomach cancer	1.68e-05	0.000194	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—RORA—stomach cancer	1.66e-05	0.000192	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPP2R1A—stomach cancer	1.66e-05	0.000192	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTP1—stomach cancer	1.63e-05	0.000188	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMOX1—stomach cancer	1.6e-05	0.000185	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CD44—stomach cancer	1.6e-05	0.000185	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDOB—stomach cancer	1.56e-05	0.00018	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TYMS—stomach cancer	1.51e-05	0.000175	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTM1—stomach cancer	1.49e-05	0.000173	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.48e-05	0.000171	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTP1—stomach cancer	1.45e-05	0.000168	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALOX5—stomach cancer	1.45e-05	0.000167	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.44e-05	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMOX1—stomach cancer	1.43e-05	0.000165	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DPYD—stomach cancer	1.42e-05	0.000165	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTP1—stomach cancer	1.42e-05	0.000164	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ERCC2—stomach cancer	1.4e-05	0.000162	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMOX1—stomach cancer	1.4e-05	0.000162	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.36e-05	0.000157	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TYMS—stomach cancer	1.35e-05	0.000156	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTP1—stomach cancer	1.33e-05	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTM1—stomach cancer	1.33e-05	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MTHFR—stomach cancer	1.32e-05	0.000153	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TYMS—stomach cancer	1.32e-05	0.000152	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMOX1—stomach cancer	1.32e-05	0.000152	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTM1—stomach cancer	1.3e-05	0.000151	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTT1—stomach cancer	1.26e-05	0.000146	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ERCC2—stomach cancer	1.25e-05	0.000145	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.24e-05	0.000144	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TYMS—stomach cancer	1.24e-05	0.000143	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTM1—stomach cancer	1.23e-05	0.000142	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ERCC2—stomach cancer	1.22e-05	0.000142	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAV1—stomach cancer	1.22e-05	0.000141	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOA1—stomach cancer	1.22e-05	0.000141	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.21e-05	0.00014	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ENO1—stomach cancer	1.18e-05	0.000136	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTHFR—stomach cancer	1.18e-05	0.000136	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.16e-05	0.000135	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ERCC2—stomach cancer	1.15e-05	0.000133	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTHFR—stomach cancer	1.15e-05	0.000133	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAV1—stomach cancer	1.09e-05	0.000126	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOA1—stomach cancer	1.08e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTHFR—stomach cancer	1.08e-05	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—stomach cancer	1.07e-05	0.000124	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAV1—stomach cancer	1.06e-05	0.000123	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOA1—stomach cancer	1.06e-05	0.000122	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CD44—stomach cancer	1.05e-05	0.000121	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.04e-05	0.00012	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAV1—stomach cancer	1e-05	0.000116	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOA1—stomach cancer	9.98e-06	0.000115	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—stomach cancer	9.63e-06	0.000111	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—stomach cancer	9.56e-06	0.000111	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—stomach cancer	9.33e-06	0.000108	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NOS3—stomach cancer	9.21e-06	0.000106	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.9e-06	0.000103	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—stomach cancer	8.79e-06	0.000102	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTP1—stomach cancer	8.73e-06	0.000101	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMOX1—stomach cancer	8.61e-06	9.95e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—stomach cancer	8.59e-06	9.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—stomach cancer	8.42e-06	9.74e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—stomach cancer	8.39e-06	9.7e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NOS3—stomach cancer	8.22e-06	9.5e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TYMS—stomach cancer	8.11e-06	9.38e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NOS3—stomach cancer	8.02e-06	9.28e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTM1—stomach cancer	8.02e-06	9.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—stomach cancer	7.9e-06	9.14e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NOS3—stomach cancer	7.56e-06	8.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ERCC2—stomach cancer	7.54e-06	8.72e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—stomach cancer	7.52e-06	8.69e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—stomach cancer	7.34e-06	8.48e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTHFR—stomach cancer	7.09e-06	8.19e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—stomach cancer	6.92e-06	8e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAV1—stomach cancer	6.54e-06	7.56e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA1—stomach cancer	6.52e-06	7.54e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—stomach cancer	5.75e-06	6.65e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CA—stomach cancer	5.18e-06	5.99e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—stomach cancer	5.17e-06	5.98e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NOS3—stomach cancer	4.94e-06	5.72e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CA—stomach cancer	4.63e-06	5.35e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—stomach cancer	4.52e-06	5.23e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CA—stomach cancer	4.52e-06	5.22e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CA—stomach cancer	4.25e-06	4.92e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.78e-06	3.22e-05	CbGpPWpGaD
